What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Hemex Health

Call Directions Website

Hemex Health focuses on commercializing proven research into cost-effective, intuitive devices optimized for the underserved world.

Hemex has developed and released a diagnostic platform (utilizing technology which received a Patents for Humanity Award) that can quickly diagnose hemoglobin disorders, such as sickle cell disease and iron deficiency anemia, from a drop of blood. Our products are designed to be easy to use and provide benefit quickly and effectively for the healthcare worker and patient on the ground, at the point-of-need.

10/08/2026

It's wonderful to be at ASCAT 2026 in London!

Our Hemex Health team is enjoying the opportunity to reconnect with colleagues, research collaborators, and supporters who share our commitment to advancing sickle cell care and expanding access to diagnostics.

We're especially excited to see our research represented at this year's conference, including a poster on fetal hemoglobin measurement from the H-PRIME study and our Gazelle Ferritin FIA study conducted in India.

We're honored that our ferritin poster was selected as one of ASCAT's Top Posters! It's exciting recognition for research exploring new opportunities to make quantitative ferritin testing more accessible.

A special thank you to the researchers, clinicians, and partners who make this work possible. It's always inspiring to come together with people who share a vision for improving patient care around the world.

09/29/2026

We’re proud to celebrate Hemex Health CEO and Co-Founder Patti White, who was named Life Science Entrepreneur of the Year at the Oregon Life Sciences Conference!

Patti also joined fellow industry leaders for a fireside chat during the conference, sharing perspectives from her experience building Hemex and working to bring innovative diagnostic technologies to patients and communities around the world.

It was an especially meaningful day for Oregon’s life sciences community. Congratulations to Heather Ellis, Executive Director of Oregon Bioscience Incubator/OTRADI, on being named Life Science Woman of the Year, and to the entire OTRADI team for the role they play in supporting entrepreneurs and helping Oregon’s bioscience community grow.

Hemex has been fortunate to be part of the OTRADI community, and we’re grateful for the people and organizations across Oregon who continue to support innovation, collaboration and the companies working to turn new ideas into better healthcare.

Congratulations to Patti, Heather and all of this year’s Oregon Life Sciences Excellence Award honorees!

Oregon Bioscience Association

09/18/2026

We’re pleased to share that Hemex Health’s John Keen, Business Development Manager for Africa, will serve as a case presenter in this upcoming Africa Sickle Cell Disease ECHO session.

The discussion will explore how better testing can support sickle cell screening, counseling and treatment monitoring.

📅 Tuesday, September 22
⏰ 7:00–8:00 p.m. EAT

Thank you to the organizers for inviting Hemex to contribute to this important conversation. See the event graphic for additional details.

09/01/2026

This September, Hemex Health joins sickle cell communities and healthcare organizations around the world in raising awareness of sickle cell disease and trait.

Many people who carry sickle cell trait do not know their status.

Greater awareness and access to testing can help people make informed decisions about their health and families.

Hemex Health products are not available in all markets, including the United States.

07/09/2026

Hemex Health, Inc. is pleased to share two recent peer-reviewed publications featuring Gazelle® in eJHaem and Blood Cells, Molecules, and Diseases.

Together, these publications add to the growing body of clinical evidence supporting Gazelle as a rapid, accurate, and accessible solution for sickle cell disease testing in decentralized care settings.

This evidence is especially meaningful as global health leaders continue to emphasize the need for earlier diagnosis and expanded access to testing. In the recent WHO guidelines, Gazelle was rated “Very accurate” for both neonates/infants and children.

We are proud to contribute to the evidence base supporting broader access to timely sickle cell disease diagnosis and care.

Read the publications:
eJHaem: [https://bit.ly/44TMJzN]
Blood Cells, Molecules, and Diseases: [ https://bit.ly/3SJQsxl]

Hemex Health products are not available in all markets, including the United States.

07/07/2026

We’re pleased to share that Hemex Health’s Gazelle® technology is referenced in the new World Health Organization (WHO) consolidated guidelines for the management of sickle-cell disease in children and adolescents.

The guidelines highlight point-of-care diagnosis and early identification as a priority area for improving care for children and adolescents living with sickle cell disease, especially in settings where access to centralized laboratory testing is limited.

This recognition reinforces the importance of the work we set out to do: bring accurate, accessible blood testing closer to the patients and healthcare teams who need it most.

We are encouraged to see growing global attention on earlier diagnosis, stronger care pathways, and more access to sickle cell testing and management.

Gazelle® products are not available for sale in the United States.
whitepdx

06/19/2026

Behind every sickle cell test is a caregiver working to reach patients sooner, guide families with answers, and connect people to the care they need.

With Gazelle®, more than 4 million tests have been conducted worldwide — supporting clinicians, nurses, counselors, and care teams as they work every day to improve access to timely sickle cell testing and care.

This World Sickle Cell Day, we recognize the caregivers whose commitment makes progress possible.

Hemex Health products are not available in all markets, including the United States.

06/14/2026

Today, Hemex Health recognizes World Blood Donor Day and extends our gratitude to the millions of voluntary blood donors around the world whose generosity helps save lives every day. ❤️🩸

As a company focused on blood health, we understand the critical role that blood donation plays in patient care. For many individuals living with conditions such as sickle cell disease, thalassemia, trauma-related injuries, and other blood disorders, access to a safe blood supply is crucial.

Our thanks to all blood donors, healthcare professionals, and blood collection organizations working to support patients and strengthen healthcare systems around the globe.

Source: World Health Organization (WHO) – World Blood Donor Day
https://www.who.int/campaigns/world-blood-donor-day

Hemex Health products are not available in all markets, including the United States.

06/04/2026

We are proud to recognize the incredible teams at Princess Marie Louise (PML) Children's Hospital and Maamobi General Hospital in Accra, Ghana.

Thank you to the nurses and healthcare workers who are helping bring sickle cell testing closer to patients every day. Your dedication strengthens care pathways and improves access to timely diagnosis and treatment, and we deeply value our partnership and shared mission.

From maternity wards and post-cesarean units to NICUs, vaccination clinics, schools, churches, and community outreach programs, Gazelle® is helping deliver diagnostics where care happens. This is point-of-care testing in action—bringing timely results closer to patients and supporting faster clinical decisions across diverse healthcare settings.

Together, we are working to expand access to sickle cell screening and care for more families and communities across Ghana.

Hemex products are not for sale in the US

05/18/2026

We were honored to see Hemex Health and the Gazelle® platform* featured in this Kenyan national news segment as part of an important initiative expanding access to sickle cell screening and care in Kenya.

On April 29, Hemex Health’s Gazelle® platform was featured during a newborn screening training initiative in the Kisumu and Nyanza regions of Kenya, with the goal of expanding access to sickle cell disease diagnostics and care.

The event brought together nurses, community health workers, and representatives from Kenya’s Ministry of Health (MOH), including Dr. Yvet Kisaka; Selina Olwanda, CEO of the Children’s Sickle Cell Foundation; Mr. Abdou Salam of Fondation Pierre Fabre; and Emily Gumbo, CEO of the Sickle Cell Federation of Kenya, to strengthen diagnostic capacity at Level 3 and 4 county hospitals.

As part of an ongoing collaboration with the MOH and AMPATH Kenya, Gazelle has been incorporated into the Afya Dhabiti program to support screening efforts for 2,000 infants ages 0–5 in Migori, Siaya, and Trans-Nzoia counties, while also supporting hydroxyurea monitoring and long-term disease management through stakeholder engagement and collaboration.

*Product not for sale in the US

Address

Portland, OR
97239

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

+19718012573

Website

http://www.hemexhealth.com/

Alerts

Be the first to know and let us send you an email when Hemex Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Loving Kindness Hypnosis

Want your business to be the top-listed health & beauty business in Portland?